Contents

Current Drug Targets - CNS & Neurological Disorders, Volume 2 - Number 4

Preface

, 2(4): ii

T. W. Rosahl and J. R. Atack


DOI: 10.2174/1568007X103020400ii




Validation of GABAA Receptor Subtypes as Potential Drug Targets by Using Genetically Modified Mice

, 2(4): 207 - 212

Thomas W. Rosahl


DOI: 10.2174/1568007033482823




Anxioselective Compounds Acting at the GABAA Receptor Benzodiazepine Binding Site

, 2(4): 213 - 232

John R. Atack


DOI: 10.2174/1568007033482841




GABAA Receptor Subtype Selective Cognition Enhancers

, 2(4): 233 - 239

Karen Maubach


DOI: 10.2174/1568007033482779




Cell Type Specificity of GABAA Receptor Mediated Signaling in the Hippocampus

, 2(4): 240 - 248

A. Semyanov


DOI: 10.2174/1568007033482832




GABAB Receptors as Potential Therapeutic Targets

, 2(4): 248 - 259

Claire-Marie Vacher and Bernhard Bettler


DOI: 10.2174/1568007033482814




GABAC Receptors as Drug Targets

, 2(4): 260 - 268

Graham A.R. Johnston, Mary Chebib, Jane R. Hanrahan and Kenneth N. Mewett


DOI: 10.2174/1568007033482805




GABA Transporters and GABA-Transaminase as Drug Targets

, 2(4): 269 - 277

Alan Sarup, Orla Miller Larsson and Arne Schousboe


DOI: 10.2174/1568007033482788




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science